These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 11303058

  • 1. Antidepressant drug-induced alterations in neuron-localized tumor necrosis factor-alpha mRNA and alpha(2)-adrenergic receptor sensitivity.
    Nickola TJ, Ignatowski TA, Reynolds JL, Spengler RN.
    J Pharmacol Exp Ther; 2001 May; 297(2):680-7. PubMed ID: 11303058
    [Abstract] [Full Text] [Related]

  • 2. Changes in noradrenergic sensitivity to tumor necrosis factor-alpha in brains of rats administered clonidine.
    Ignatowski TA, Chou RC, Spengler RN.
    J Neuroimmunol; 1996 Oct; 70(1):55-63. PubMed ID: 8862135
    [Abstract] [Full Text] [Related]

  • 3. Antidepressant drug administration modifies the interactive relationship between alpha(2)-adrenergic sensitivity and levels of TNF in the rat brain.
    Nickola TJ, Ignatowski TA, Spengler RN.
    J Neuroimmunol; 2000 Jul 10; 107(1):50-8. PubMed ID: 10808050
    [Abstract] [Full Text] [Related]

  • 4. Neuronal-associated tumor necrosis factor (TNF alpha): its role in noradrenergic functioning and modification of its expression following antidepressant drug administration.
    Ignatowski TA, Noble BK, Wright JR, Gorfien JL, Heffner RR, Spengler RN.
    J Neuroimmunol; 1997 Oct 10; 79(1):84-90. PubMed ID: 9357451
    [Abstract] [Full Text] [Related]

  • 5. Tumor necrosis factor-alpha: presynaptic sensitivity is modified after antidepressant drug administration.
    Ignatowski TA, Spengler RN.
    Brain Res; 1994 Dec 05; 665(2):293-9. PubMed ID: 7895065
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. An antidepressant mechanism of desipramine is to decrease tumor necrosis factor-alpha production culminating in increases in noradrenergic neurotransmission.
    Reynolds JL, Ignatowski TA, Sud R, Spengler RN.
    Neuroscience; 2005 Dec 05; 133(2):519-31. PubMed ID: 15878644
    [Abstract] [Full Text] [Related]

  • 8. Brain-derived tumor necrosis factor-alpha and its involvement in noradrenergic neuron functioning involved in the mechanism of action of an antidepressant.
    Reynolds JL, Ignatowski TA, Sud R, Spengler RN.
    J Pharmacol Exp Ther; 2004 Sep 05; 310(3):1216-25. PubMed ID: 15082752
    [Abstract] [Full Text] [Related]

  • 9. Brain-derived TNFalpha: involvement in neuroplastic changes implicated in the conscious perception of persistent pain.
    Covey WC, Ignatowski TA, Knight PR, Spengler RN.
    Brain Res; 2000 Mar 17; 859(1):113-22. PubMed ID: 10720620
    [Abstract] [Full Text] [Related]

  • 10. Autoreceptor-mediated inhibition of norepinephrine release in rat medial prefrontal cortex is maintained after chronic desipramine treatment.
    Garcia AS, Barrera G, Burke TF, Ma S, Hensler JG, Morilak DA.
    J Neurochem; 2004 Nov 17; 91(3):683-93. PubMed ID: 15485498
    [Abstract] [Full Text] [Related]

  • 11. Activation and desensitization by cyclic antidepressant drugs of alpha2-autoreceptors, alpha2-heteroreceptors and 5-HT1A-autoreceptors regulating monamine synthesis in the rat brain in vivo.
    Esteban S, Lladó J, Sastre-Coll A, García-Sevilla JA.
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Aug 17; 360(2):135-43. PubMed ID: 10494882
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Antinociception mediated by alpha(2)-adrenergic activation involves increasing tumor necrosis factor alpha (TNFalpha) expression and restoring TNFalpha and alpha(2)-adrenergic inhibition of norepinephrine release.
    Spengler RN, Sud R, Knight PR, Ignatowski TA.
    Neuropharmacology; 2007 Feb 17; 52(2):576-89. PubMed ID: 17055005
    [Abstract] [Full Text] [Related]

  • 14. Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: II. In vitro studies in the rat.
    Béïque J, de Montigny C, Blier P, Debonnel G.
    Neuropharmacology; 2000 Jul 24; 39(10):1813-22. PubMed ID: 10884562
    [Abstract] [Full Text] [Related]

  • 15. Blockade of autoreceptor-mediated inhibition of norepinephrine release by atipamezole is maintained after chronic reuptake inhibition.
    Lapiz MD, Zhao Z, Bondi CO, O'Donnell JM, Morilak DA.
    Int J Neuropsychopharmacol; 2007 Dec 24; 10(6):827-33. PubMed ID: 17697440
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of acute, short- and long-term milnacipran administration on rat locus coeruleus noradrenergic and dorsal raphe serotonergic neurons.
    Mongeau R, Weiss M, de Montigny C, Blier P.
    Neuropharmacology; 1998 Jul 24; 37(7):905-18. PubMed ID: 9776386
    [Abstract] [Full Text] [Related]

  • 18. Inhibitory effect of antidepressants on the NMDA-evoked [(3)H]noradrenaline release from rat hippocampal slices.
    Mayer A, Szasz BK, Kiss JP.
    Neurochem Int; 2009 Nov 24; 55(6):383-8. PubMed ID: 19393275
    [Abstract] [Full Text] [Related]

  • 19. Effects of the selective norepinephrine reuptake inhibitor reboxetine on norepinephrine and serotonin transmission in the rat hippocampus.
    Szabo ST, Blier P.
    Neuropsychopharmacology; 2001 Dec 24; 25(6):845-57. PubMed ID: 11750178
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.